Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 Feb 20;15:1382832. doi: 10.3389/fimmu.2024.1382832

Corrigendum: Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension

Chen-Yu Jiang 1,2,†, Li-Wei Wu 1,2,†, Yi-Wei Liu 1,2, Bei Feng 1,2, Lin-Cai Ye 1,2, Xu Huang 1,2, Yang-Yang He 3, Yi Shen 1,2, Yi-Fan Zhu 1,2, Xing-Liang Zhou 1,2, Dai-Ji Jiang 1,2, Hai-Kun Qi 4,*,‡, Hao Zhang 1,2,*,‡, Yi Yan 1,2,*,‡
PMCID: PMC10912855  PMID: 38444849

In the original article, there was a mistake in the Funding statement as published. The Projects of National Natural Science Foundation of China (82200065, 82000064) were wrong. The correct Funding statement appears below.

FUNDING

“This work was supported by the Project of National Natural Science Foundation of China (U20A2018), the Project of Shanghai Municipal Science and Technology Commission (20MC1920400), the National Key Research and Development Program of China (2022YFC2703102), Projects of National Natural Science Foundation of China (82200065, 82241007), Shanghai Pujiang Program (22PJ1410100), Young Talent Program of Shanghai Municipal Health Commission (2022YQ070) and Innovative research team of high-level local universities in Shanghai.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES